VHL Research

The Cancer in Our Genes International Databank (CGIP) is Here!  Participate Now!

databank button

 


The VHL Alliance announces a new competitive research grant cycle with a total funding of $150,000.

To date, the VHL Alliance has awarded over $1.4 million to support VHL research. See details


Increase in Life Expectancy: link to article

Thanks to advances in medical research, clinical guidelines for screening, diagnosis, and treatment have been developed which have contributed to extending VHL patient life expectancy by over 16 years! Our hope is that through continued research efforts, we will find ways of keeping tumors from forming, or at least keeping them small, and reduce the need for surgical intervention.


Updated Compilation of VHL Gene Mutations and associated patient phenotypes: Provided by Dr. Rachel Giles

 

If information from this database is used for publication, please cite the following:
Genetic Analysis of von Hippel-Lindau Disease. Nordstrom-O’Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH. Hum Mutat. 2010 May;31(5):521-37. doi: 10.1002/humu.21219. PMID: 20151405


Please remember, accomplishing these efforts is dependent on your financial contribution or fundraising efforts!
Together we can uncover a cure!

great non-profile
verified vhl authorize.net
Belgium   Brazil   Canada   China   Croatia   Denmark   France   Germany   Great Britain   Greece   Hungary   Ireland   Italy   Japan   Lithuania   Netherlands   Norway   Poland   Portugal   Spain   Switzerland   Sweden   Turkey  
©2014 by The VHL Alliance. All Rights Reserved.
The VHL Alliance is a tax exempt 503(c)3 corporation
Last Modified: August 7, 2014




This website is certified by Health On the Net Foundation. </a>Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.